IRADIMED CORPORATION Participates in the 2025 Wells Fargo Healthcare Conference
IRADIMED CORPORATION (NASDAQ: IRMD), renowned for its pioneering work in MRI-compatible medical devices, is gearing up for a significant presence at the upcoming Wells Fargo 2025 Healthcare Conference, taking place from September 3-5, 2025, in a vibrant location that fosters innovation in the healthcare sector.
The company's President and CEO, Roger Susi, along with CFO Jack Glenn, will engage in one-on-one investor meetings on September 4, enhancing their connection with stakeholders in the healthcare community.
What to Expect at the Conference
The Wells Fargo Healthcare Conference is a prestigious annual gathering that attracts leading healthcare companies, institutional investors, and key industry players. Here, discussions will revolve around prevailing trends, groundbreaking innovations, and promising investment opportunities that continue to reshape the landscape of healthcare.
Industry Collaboration
This unique event serves as a platform for IRADIMED CORPORATION to showcase its cutting-edge solutions that are vital in patient management during MRI procedures. As healthcare evolves, the importance of collaboration and sharing insights on advancements cannot be overstated.
About IRADIMED CORPORATION
IRADIMED CORPORATION is at the forefront of developing state-of-the-art MRI-compatible medical devices. The company is dedicated to designing, manufacturing, marketing, and distributing a range of MRI-compatible products, which include essential medical devices, accessories, and disposable items.
Innovative Product Offerings
IRADIMED is recognized as the exclusive provider of a non-magnetic intravenous infusion pump system designed specifically for safe operation during MRI procedures. This innovation is crucial as conventional infusion pumps often contain magnetic components that could cause interference within MRI environments.
The MRidium® MRI-compatible IV infusion pump system, with its non-magnetic ultrasonic motor and carefully crafted non-ferrous parts, allows for a reliable and secure fluid delivery process. This feature is indispensable for critical patients who cannot be disconnected from their medication or for children, who frequently require sedation during MRI scans.
Advancements in Patient Monitoring
The company's 3880 MRI-compatible patient vital signs monitoring system is another groundbreaking product, specifically designed to monitor patients efficiently during MRI procedures. Featuring a battery of non-magnetic components, the Iradimed 3880 operates effectively within magnetic environments up to 30,000 gauss.
This design not only preserves the patient's safety but also ensures continuous monitoring, reducing the time critically ill patients spend away from their care units. The Iradimed 3880 boasts wireless ECG monitoring and utilizes advanced Masimo® algorithms, demonstrating the commitment to high-quality patient care.
Enhanced Monitoring Features
Key functionalities of the Iradimed 3880 include wireless SpO2 monitoring, non-magnetic respiratory CO2 analysis, and both invasive and non-invasive blood pressure monitoring. Additionally, the device can accommodate temperature measurement and an advanced multi-gas anesthetic agent unit that continuously assesses Minimum Alveolar Concentration.
These features equip healthcare providers with vital real-time information, enhancing decision-making during critical moments of patient care.
Connecting with IRADIMED CORPORATION
To learn more about how IRADIMED CORPORATION is transforming the world of MRI-compatible medical devices, you are encouraged to visit www.iradimed.com.
For inquiries or additional information, the IRADIMED CORPORATION team can be reached at (407) 677-8022 or through their investor relations email at InvestorRelations@iradimed.com.
Frequently Asked Questions
What is the purpose of attending the Wells Fargo Healthcare Conference?
The event serves as a crucial platform for IRADIMED to showcase its innovations and connect with potential investors and partners in the healthcare industry.
How does IRADIMED ensure the safety of its IV infusion pumps?
The company utilizes non-magnetic components and a specialized design to prevent radio frequency interference, ensuring safety during MRI procedures.
What are the notable features of the Iradimed 3880 monitoring system?
Features include wireless monitoring, non-invasive blood pressure readings, and advanced algorithms for accurate patient assessment during MRI procedures.
Where can I find more information about IRADIMED’s products?
More details can be found on their official website, which provides comprehensive information about their innovative medical devices and services.
Who can I contact for investor relations inquiries?
Individuals interested in investor relations can contact IRADIMED CORPORATION at (407) 677-8022 or email them at InvestorRelations@iradimed.com.
